Roche is adding a new module to its mySugar app, called mySugar Pump Control, that lets users control their Accu-Chek Insight insulin pump virtually.
Patients using the new tool are able to import data, view status and remotely deliver a standard bolus. Additionally, users can tap into the mySugar Bolus Calculator, which assists users in calculating the level of insulin needed for a meal and...
Roche's diabetes management app mySugr's Logbook is now integrating with Novo Nordisk's connected insulin pens: the NovoPen 6 and NovoPen Echo Plus.
Patients will be able connect the mySugr Logbook to their smart-pen device in order to create more data set and reports with more insights. According to the companies, the goal is to be able to share more insights with healthcare providers in order...
The relationship between global pharmaceutical company Roche and digital diabetes management app maker mySugr has been growing for the past couple of years. First there was the investment, then there was the partnership, and now Roche is going all in and becoming the exclusive shareholder of mySugr.
Under the agreement, mySugr will continue to function as a separate legal entity, but will serve...
App-based doctor house call company Pager will incorporate PokitDok’s healthcare price comparison tool into its care navigation platform. In addition to the ability to find board-certified doctors, registered nurses, physician assistants and nurse practitioners and arrange either in-home or telemedicine visits (or refer to a specialist) Pager customers will also be able to verify insurance or...
Vienna and San Diego-based digital health company mySugr has come out of the International Conference on Advanced Technologies and Treatments for Diabetes with two big pieces of news: study results that show impressive efficacy of the app in high-risk populations and an expansion of its partnership with Roche.
The study looked at 440 mySugr users randomly selected from a group of high-risk (HbA1C...
More than two years ago, when Apple first added a list of diabetes management apps to its app store, we covered the list of 13 top picks. A lot can change in a few years, however. And while a few of those same apps still appear on Apple’s current list of 12 diabetes management apps, there’s plenty of new names — though not all new to MobiHealthNews readers — as well.
Read on for Apple’s current...
Austria and San Diego-based MySugr, a diabetes management coaching app announced a partnership with Abbott in the UK. Abbott has a wearable interstitial glucose monitor called the FreeStyle Libre Flash Glucose Monitoring System. The system, which is not yet available in the US, consists of a patch that continually reads blood glucose and an NFC reader device that the user can hold over the patch...
Austria and San Diego-based mySugr has added coaching to the premium version of its mySugr Logbook app, the company announced this week.
"What we want to do is create a digital diabetes clinic," North American Managing Director Kyle J. Rose said today at the Digital Medicine Connect event in Boston. "What we’ve decided to do is actually work with diabetes educators as coaches. Because, as...
About a year after pharmaceutical company Roche announced an investment in diabetes app company mySugr, the companies announced an integration partnership.
MySugr offers a handful of apps, but its flagship is called Diabetes Logbook, which is designed for people with type 1 or type 2 diabetes and includes logging, graphing, analysis, and Apple Health integration. If users sign up for a month-to-...
Austria-based diabetes app company mySugr has raised $4.8 million from Roche Ventures and iSeed Ventures. Existing investor XLHealth also contributed to the round, which will help mySugr scale up its user base in the US and other other countries. iSeed Ventures is a new fund that has only made a half dozen investments so far, and it is led by former iHealth Lab head Adam Lin.
MySugr offers a...
